德尤比基酶TRIM44促进在扩散大B细胞淋巴瘤中自介导的化学抵抗
Yan Wang1, Banban Li1, Yanan Zhao2
1Department of Hematology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
Hematological oncology
|July 18, 2025
概括
含有44 (TRIM44) 的三部分基因通过激活自促使扩散型大B细胞淋巴瘤 (DLBCL) 的生长和化学抵抗. miR-665/TRIM44轴驱动DLBCL的进展,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤亚型.
- TRIM家族蛋白质,含有44 (TRIM44) 的三方基因,与瘤发育有关,并在各种癌症中过度表达.
- TRIM44在DLBCL病变发生中的特定作用以前没有被描述.
研究的目的:
- 为了阐明TRIM44在DLBCL中的功能.
- 调查TRIM44影响DLBCL进展和化疗抵抗的机制.
- 在DLBCL中确定miR-665和TRIM44之间的监管关系.
主要方法:
- 在DLBCL细胞系 (DB和SU-DHL-4) 上进行了功能增加和丧失的研究.
- 评估了自标志物 (LC3II/LC3-I比,贝克林1,自细胞) 和增殖标志物 (Ki67,PCNA).
- 评估了对多克索鲁比的化学抵抗性.
- 在小鼠体内进行了体内研究.
- 使用微RNA (miRNA) 下拉和光酶记者测试来确认直接向.
主要成果:
- TRIM44的过度表达增强了DLBCL细胞的增殖和活力,而TRIM44的沉默抑制了增殖和诱导了亡.
- TRIM44上调自标志物和增加自细胞形成,表明自激活.
- 通过增强的自活动,TRIM44在DLBCL细胞中赋予了多克索鲁比辛化学抵抗.
- 在体内研究表明,TRIM44的过度表达促进了瘤生长.
- TRIM44被确定为瘤抑制剂miR-665.5的直接目标.
结论:
- TRIM44通过增强自介导化学抵抗来促进DLBCL的进展.
- 在DLBCL病变发生过程中,miR-665/TRIM44轴起着至关重要的作用.
- 准miR-665/TRIM44通路可能是DLBCL的新治疗策略.
相关概念视频
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Delivery Pathways to the Lysosome
7.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.2K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


